Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: Co-delivery of anionic epitope/CpG vaccine and IDO inhibitor by self-assembled cationic liposomes for combination melanoma immunotherapy

Qi Su ab, Changrong Wang c, Huijuan Song d, Chuangnian Zhang b, Jinjian Liu *d, Pingsheng Huang b, Yumin Zhang d, Jianhua Zhang *a and Weiwei Wang *b
aDepartment of Polymer Science and Technology, Key Laboratory of Systems Bioengineering of the Ministry of Education, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China. E-mail: jhuazhang@tju.edu.cn
bTianjin Key Laboratory of Biomaterial Research Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China. E-mail: wwwangtj@163.com; wangww@bme.pumc.edu.cn
cSchool of Pharmacy, Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, Guanhai Road 346, Yantai 264003, China
dTianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China. E-mail: liujinjian2002@163.com

Received 12th May 2021 , Accepted 12th May 2021

First published on 20th May 2021


Abstract

Correction for ‘Co-delivery of anionic epitope/CpG vaccine and IDO inhibitor by self-assembled cationic liposomes for combination melanoma immunotherapy’ by Qi Su et al., J. Mater. Chem. B, 2021, 9, 3892–3899, DOI: 10.1039/d1tb00256b.


The authors note that the name of co-author Jianhua Zhang was spelled incorrectly in the author list of this article. The corrected spelling has been included in the revised author list above.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2021
Click here to see how this site uses Cookies. View our privacy policy here.